On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the treatment of opioid overdose. The treatment is used to treat opioid ...

Purdue Pharma has asked the federal Food and Drug Administration (FDA) to approve a new, auto-injectable form of one of its drugs to treat opioid overdoses. The Stamford-based biopharmaceutical ...

Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...

The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and pharmaceutical delivery systems. According to a FutureWise Research analysis, ...

The growth potential of the weight-loss market could explode with advances, notably GLP-1 pills, and broader insurance coverage. That should change both health outcomes and the way Americas buy and ...